Pazopanib Hydrochloride

CAS 635702-64-6 13 current records 1 historicalSmall Molecule

Who holds supplier records for Pazopanib Hydrochloride? 13 organisations hold a current record for Pazopanib Hydrochloride: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (9), China (2), Taiwan (1) and Spain (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Pazopanib Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/pazopanib-hydrochloride

Reading the evidence

  • 13 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    9 of the 13 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 11 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (13)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Pazopanib Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • CDYMAX (INDIA) PHARMA PRIVATE LIMITED
    Active DMF 33054 · latest filing Jul 2018
    India Company GMP cert on record
  • Cipla Limited
    Active DMF 32899 · latest filing Jul 2018
    India Company GMP cert on record
  • Dr. Reddy's Laboratories Ltd.
    Active DMF 35732 · latest filing Mar 2021
    India Company GMP cert on record
  • Formosa Laboratories, Inc.
    Active DMF 31297 · latest filing Jan 2017
    Taiwan Company GMP cert on record
  • Granules India Limited
    Active DMF 36037 · latest filing Jun 2021
    India Company GMP cert on record
  • Hetero Labs Limited
    Active DMF 26207 · latest filing Jul 2012
    India Company GMP cert on record
  • Laurus Labs Limited
    Active DMF 36689 · latest filing Feb 2022
    India Company GMP cert on record
  • MEDICHEM SA
    Active DMF 36192 · latest filing Oct 2021
    Spain Company GMP cert on record
  • MSN Laboratories Private Limited
    Active DMF 27422 · latest filing Aug 2013
    India Company GMP cert on record
  • Shandong Loncom Pharmaceutical Co.,ltd.
    Active DMF 44282 · latest filing Jun 2026
    China
  • Sun Pharmaceutical Industries Limited
    Active DMF 36550 · latest filing Feb 2022
    India Company GMP cert on record
  • SYNTHIMED LABS PRIVATE LIMITED
    Active DMF 41481 · latest filing May 2025
    India Company GMP cert on record
  • ZHEJIANG LEPU PHARMACEUTICAL CO., LTD.
    Active DMF 34146 · latest filing Nov 2019
    China
Need Pazopanib Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (1)

Organisations whose Type II DMFs for Pazopanib Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 1 historical record

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Pazopanib Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201733).

Chemical identity

IUPAC name
5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;hydrochloride
Canonical SMILES
CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N.Cl
InChIKey
MQHIQUBXFFAOMK-UHFFFAOYSA-N
Synonyms
GW-786034B, GW786034B, Pazopanib (as hydrochloride), Pazopanib hcl, Pazopanib hydrochloride, Pazopanib monohydrochloride, Votrient, CHEBI:71217, NSC737754, PAZOPANIB HYDROCHLORIDE (MART.), PAZOPANIB HYDROCHLORIDE [MART.], RefChem:55813

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Kinase Inhibitor
Mechanism of action
Cytochrome P450 2C8 Inhibitors; Cytochrome P450 2D6 Inhibitors; Cytochrome P450 3A4 Inhibitors; Protein Kinase Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Pazopanib Hydrochloride?

13 organisations hold an active US FDA Type II Drug Master File or a CEP for Pazopanib Hydrochloride: CDYMAX (INDIA) PHARMA PRIVATE LIMITED (India), Cipla Limited (India), Dr. Reddy's Laboratories Ltd. (India), Formosa Laboratories, Inc. (Taiwan), Granules India Limited (India), Hetero Labs Limited (India), Laurus Labs Limited (India) and MEDICHEM SA (Spain), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Pazopanib Hydrochloride Drug Master Files are active?

CDYMAX (INDIA) PHARMA PRIVATE LIMITED (DMF 33054), Cipla Limited (DMF 32899), Dr. Reddy's Laboratories Ltd. (DMF 35732), Formosa Laboratories, Inc. (DMF 31297), Granules India Limited (DMF 36037), Hetero Labs Limited (DMF 26207), Laurus Labs Limited (DMF 36689) and MEDICHEM SA (DMF 36192) and 5 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Pazopanib Hydrochloride records mean?

1 organisation has only inactive Type II DMFs for Pazopanib Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Pazopanib Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Pazopanib Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.